Evidence map›Paper›PMID 29133930›Full record

ArticleNature communications2017

PLCγ-dependent mTOR signalling controls IL-7-mediated early B cell development.

Mei Yu, Yuhong Chen, Hu Zeng, Yongwei Zheng, Guoping Fu, Wen Zhu, Ulrich Broeckel, Praful Aggarwal, Amy Turner, Geoffrey Neale and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 49 citations in OpenAlex.

  1. Phospholipases: Where Do We Stand?Methods in molecular biology (Clifton, N.J.) · 2027
    Review
  2. Article
  3. Article
  4. Cellular signaling pathway of Shiga toxin-induced ATP release.Frontiers in cellular and infection microbiology · 2026
    Article
  5. Review
  6. Review
  7. Observational
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Advances in IL-7 Research on Tumour Therapy.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  16. Review
  17. Article
  18. CARD19, a Novel Regulator of the TAK1/NF-κB Pathway in Self-Reactive B Cells.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Mei YuBlood Research Institute, Blood Center of Wisconsin, Milwaukee, WI, 53226, USA.
Yuhong ChenBlood Research Institute, Blood Center of Wisconsin, Milwaukee, WI, 53226, USA.
Hu ZengDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.ORCID http://orcid.org/0000-0002-9909-7732
Yongwei ZhengBlood Research Institute, Blood Center of Wisconsin, Milwaukee, WI, 53226, USA.
Guoping FuBlood Research Institute, Blood Center of Wisconsin, Milwaukee, WI, 53226, USA.
Wen ZhuBlood Research Institute, Blood Center of Wisconsin, Milwaukee, WI, 53226, USA.
Ulrich BroeckelSection of Genomic Pediatrics, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Praful AggarwalSection of Genomic Pediatrics, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Amy TurnerSection of Genomic Pediatrics, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Geoffrey NealeHartwell Center for Bioinformatics and Biotechnology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.ORCID http://orcid.org/0000-0003-3776-0858
Cliff GuyDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Nan ZhuBlood Research Institute, Blood Center of Wisconsin, Milwaukee, WI, 53226, USA.
Hongbo ChiDepartment of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
Renren WenBlood Research Institute, Blood Center of Wisconsin, Milwaukee, WI, 53226, USA.
Demin WangBlood Research Institute, Blood Center of Wisconsin, Milwaukee, WI, 53226, USA. demin.wang@bcw.edu.
Versiti Blood Center of Wisconsin · USSt. Jude Children's Research Hospital · USMedical College of Wisconsin · USFujian Normal University · CN

Funding

B cell responses in heparin-induced thrombocytopeniaR01HL130724 · NHLBI · VERSITI WISCONSIN, INC. · PI WANG, DEMIN · 2017 to 2024
$4.8M
PLC?s in B cell biology and autoimmunityR01AI079087 · NIAID · VERSITI WISCONSIN, INC. · PI WANG, DEMIN · 2008 to 2018
$4.4M
The MKP-1/p38 axis: coordinating innate and adaptive immunityR01NS064599 · NINDS · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHI, HONGBO · 2008 to 2018
$3.7M
Metabolic checkpoint in dendritic cell subsets and adaptive immunityR37AI105887 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Hongbo Chi · 2019 to 2026
$3.6M
Metabolic checkpoint in TH17 cell differentiationR01AI105887 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHI, HONGBO · 2014 to 2018
$2.2M
mTOR signaling in T cell quiescenceR01AI101407 · NIAID · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHI, HONGBO · 2013 to 2017
$2.2M
Tsc1/mTOR axis in immune homeostasis and tumorigenesisR01CA176624 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHI, HONGBO · 2014 to 2018
$1.9M
NCI NIH HHS R01 CA176624NHLBI NIH HHS R01 HL130724NIAID NIH HHS R01 AI079087NIAID NIH HHS R01 AI101407NIAID NIH HHS R01 AI105887NIAID NIH HHS R37 AI105887NINDS NIH HHS R01 NS064599
6 · The paper itself

Abstract

The precise molecular mechanism underlying the regulation of early B cell lymphopoiesis is unclear. The PLCγ signaling pathway is critical for antigen receptor-mediated lymphocyte activation, but its function in cytokine signaling is unknown. Here we show that PLCγ1/PLCγ2 double deficiency in mice blocks early B cell development at the pre-pro-B cell stage and renders B cell progenitors unresponsive to IL-7. PLCγ pathway inhibition blocks IL-7-induced activation of mTOR, but not Stat5. The PLCγ pathway activates mTOR through the DAG/PKC signaling branch, independent of the conventional Akt/TSC/Rheb signaling axis. Inhibition of PLCγ/PKC-induced mTOR activation impairs IL-7-mediated B cell development. PLCγ1/PLCγ2 double-deficient B cell progenitors have reduced expression of genes related to B cell lineage, IL-7 signaling, and cell cycle. Thus, IL-7 receptor controls early B lymphopoiesis through activation of mTOR via PLCγ/DAG/PKC signaling, not via Akt/Rheb signaling.

Indexed as

AnimalsFemaleInterleukin-7LymphopoiesisMaleMiceMice, Inbred C57BLMice, KnockoutPhospholipase C gammaPrecursor Cells, B-LymphoidSignal TransductionSTAT5 Transcription FactorTOR Serine-Threonine KinasesInterleukin-7mTOR protein, mousePhospholipase C gammaSTAT5 Transcription FactorTOR Serine-Threonine Kinases

Identifiers

PMID29133930
PMCPMC5684131
OpenAlexW2767612549

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.